Evaluation of immunomodulatory drugs in multiple myeloma: single center experience. | Am J Blood Res;5(2): 95-100, 2015. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Evaluation of immunomodulatory drugs in multiple myeloma: single center experience.

Ozkan, Melda Comert; Tombuloglu, Murat; Sahin, Fahri; Saydam, Guray.

Affiliation

Ozkan MC; Department of Hematology, Ege University Medical School Izmir, Turkey.
Tombuloglu M; Department of Hematology, Ege University Medical School Izmir, Turkey.
Sahin F; Department of Hematology, Ege University Medical School Izmir, Turkey.
Saydam G; Department of Hematology, Ege University Medical School Izmir, Turkey.

Am J Blood Res ; 5(2): 95-100, 2015.

Article in En | MEDLINE | ID: mdl-27069758

Key words

Multiple myeloma; immunomodulatory drugs; lenalidomide; thalidomide

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Am J Blood Res Year: 2015 Document type: Article Affiliation country: Turkey Country of publication: United States

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Am J Blood Res Year: 2015 Document type: Article Affiliation country: Turkey Country of publication: United States